Amber Therapeutics
About:
Amber Therapeutics develops the next-generation of bioelectrical therapies.
Website: https://www.amber-tx.com/
Top Investors: F-Prime Capital, Innovate UK, 8VC, New Enterprise Associates, Oxford Science Enterprises
Description:
Amber Therapeutics develops the next-generation of bioelectrical therapies that can sense and adapt as well as stimulate, with the potential to radically improve clinical outcomes in patients with functional disorders of the peripheral nervous system.
Total Funding Amount:
81.1M GBP
Headquarters Location:
London, England, United Kingdom
Founded Date:
2021-01-01
Founders:
Number of Employees:
11-50
Last Funding Date:
2024-06-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai